CUE Historical Earnings image   This CUE historical earnings page last updated 7/9/2024
CUE Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20245/9/20240.00B
Q4 20234/8/20240.00B
Q3 202311/3/20230.00B
Q2 20238/9/20230.00B
Q1 20235/9/20230.00B
Q4 20223/21/20230.00B
Q3 202211/14/20220.07M
Q2 20228/4/20220.03M
Q1 20225/10/20220.00B
Q4 20213/16/20220.01B
Q3 202110/27/20210.00B
Q2 20218/17/20210.00B
Q1 20215/17/20210.00B
Q4 20203/16/20210.00B
Q3 202011/9/20200.00B
Q2 20208/10/20200.00B
Q1 20205/19/20200.00B
Q4 20193/17/20200.00B
Q3 201911/12/20190.00B
Q2 20198/8/20190.00B
Q1 20195/8/20190.00B
Q4 20183/14/20190.00B
Q3 201811/13/20180.00B
Q2 20188/13/20180.00B
CUE Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20245/9/2024-0.250
Q4 20234/8/2024-0.280
Q3 202311/3/2023-0.240
Q2 20238/9/2023-0.290
Q1 20235/9/2023-0.290
Q4 20223/21/2023-0.370
Q3 202211/14/2022-0.310
Q2 20228/4/2022-0.370
Q1 20225/10/2022-0.440
Q4 20213/16/2022-0.250
Q3 202110/27/2021-0.410
Q2 20218/17/2021-0.330
Q1 20215/17/2021-0.410
Q4 20203/16/2021-0.370
Q3 202011/9/2020-0.340
Q2 20208/10/2020-0.380
Q1 20205/19/2020-0.480
Q4 20193/17/2020-0.370
Q3 201911/12/2019-0.310
Q2 20198/8/2019-0.460
Q1 20195/8/2019-0.540
Q4 20183/14/2019-0.580
Q3 201811/13/2018-0.620
Q2 20188/13/2018-0.360
Quotes delayed 20 minutes

Email EnvelopeFree CUE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cue Biopharma (CUE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CUTR Historical Earnings
CVRX Historical Earnings
CVS Historical Earnings
CWBR Historical Earnings
CYCC Historical Earnings
CYCN Historical Earnings
CYH Historical Earnings
CYRX Historical Earnings
CYT Historical Earnings
CYTH Historical Earnings
What was the record high CUE historical earnings result?
In terms of earnings or revenue, what is the best CUE historical earnings result that Cue Biopharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CUE historical earnings result was set in Q3 2023, when Cue Biopharma posted results of -0.240/share. The most successful revenue quarter within our data set was Q4 2021 when Cue Biopharma reported revenue of 0.01B.

What was the lowest Cue Biopharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CUE has reported, and when?

✔️Accepted answer: Within our data set, the lowest CUE historical earnings result was set in Q3 2018, when Cue Biopharma posted results of -0.620/share. The smallest revenue quarter within our data set was Q2 2022 when Cue Biopharma reported revenue of 0.03M.

On this page we presented the CUE historical earnings date information for Cue Biopharma. Reviewing that CUE Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2023, when CUE posted gaap of -0.240/share. Meanwhile the lowest CUE historical earnings result was in Q3 2018, when CUE posted gaap of -0.620/share. Moving to Cue Biopharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when CUE reported 0.01B in revenue, while the smallest revenue quarter was Q2 2022 when CUE reported 0.03M in revenue.

For self directed investors doing their due diligence on CUE or any other given stock, their research can benefit from looking into all of the Cue Biopharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Cue Biopharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CUE. Thanks for visiting, and the next time you need to research CUE historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: FTRI Videos, SID Stock Predictions, Institutional Holders of CEMI.


CUE Historical Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.